The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples